LUMOS PHARMA, INC. Quarterly Return On Assets in % from Q2 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Lumos Pharma, Inc. quarterly/annual Return On Assets history and growth rate from Q2 2012 to Q3 2024.
  • Lumos Pharma, Inc. Return On Assets for the quarter ending September 30, 2024 was -130 %, a 138% decline year-over-year.
  • Lumos Pharma, Inc. annual Return On Assets for 2023 was -65.3 %, a 73.5% decline from 2022.
  • Lumos Pharma, Inc. annual Return On Assets for 2022 was -37.6 %, a 36.4% decline from 2021.
  • Lumos Pharma, Inc. annual Return On Assets for 2021 was -27.6 %, a 656% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -130 -75.2 -138% Jul 1, 2024 Sep 30, 2024
Q2 2024 -104 -57 -122% Apr 1, 2024 Jun 30, 2024
Q1 2024 -85.9 -45.1 -110% Jan 1, 2024 Mar 31, 2024
Q4 2023 -65.3 -27.7 -73.5% Oct 1, 2023 Dec 31, 2023
Q3 2023 -54.7 -22.9 -72% Jul 1, 2023 Sep 30, 2023
Q2 2023 -46.8 -17 -57.2% Apr 1, 2023 Jun 30, 2023
Q1 2023 -40.8 -12.3 -43.2% Jan 1, 2023 Mar 31, 2023
Q4 2022 -37.6 -10 -36.4% Oct 1, 2022 Dec 31, 2022
Q3 2022 -31.8 -8.62 -37.2% Jul 1, 2022 Sep 30, 2022
Q2 2022 -29.8 -15.4 -107% Apr 1, 2022 Jun 30, 2022
Q1 2022 -28.5 -18 -171% Jan 1, 2022 Mar 31, 2022
Q4 2021 -27.6 -23.9 -656% Oct 1, 2021 Dec 31, 2021
Q3 2021 -23.2 -13.9 -150% Jul 1, 2021 Sep 30, 2021
Q2 2021 -14.4 -0.72 -5.27% Apr 1, 2021 Jun 30, 2021
Q1 2021 -10.5 +2.16 +17.1% Jan 1, 2021 Mar 31, 2021
Q4 2020 -3.65 +13.6 +78.8% Oct 1, 2020 Dec 31, 2020
Q3 2020 -9.27 +5.42 +36.9% Jul 1, 2020 Sep 30, 2020
Q2 2020 -13.7 +3.75 +21.5% Apr 1, 2020 Jun 30, 2020
Q1 2020 -12.7 +14.7 +53.6% Jan 1, 2020 Mar 31, 2020
Q4 2019 -17.2 +19.5 +53.1% Oct 1, 2019 Dec 31, 2019
Q3 2019 -14.7 +21.1 +59% Jul 1, 2019 Sep 30, 2019
Q2 2019 -17.4 +26.8 +60.6% Apr 1, 2019 Jun 30, 2019
Q1 2019 -27.3 +17.3 +38.8% Jan 1, 2019 Mar 31, 2019
Q4 2018 -36.8 +10.7 +22.6% Oct 1, 2018 Dec 31, 2018
Q3 2018 -35.8 +12 +25.1% Jul 1, 2018 Sep 30, 2018
Q2 2018 -44.2 -2.92 -7.08% Apr 1, 2018 Jun 30, 2018
Q1 2018 -44.6 +3.1 +6.5% Jan 1, 2018 Mar 31, 2018
Q4 2017 -47.5 -1.48 -3.22% Oct 1, 2017 Dec 31, 2017
Q3 2017 -47.8 -0.28 -0.59% Jul 1, 2017 Sep 30, 2017
Q2 2017 -41.2 +4.15 +9.14% Apr 1, 2017 Jun 30, 2017
Q1 2017 -47.7 -13.8 -40.8% Jan 1, 2017 Mar 31, 2017
Q4 2016 -46 -29 -170% Oct 1, 2016 Dec 31, 2016
Q3 2016 -47.6 -89.7 -213% Jul 1, 2016 Sep 30, 2016
Q2 2016 -45.4 -99.8 -183% Apr 1, 2016 Jun 30, 2016
Q1 2016 -33.9 -104 -148% Jan 1, 2016 Mar 31, 2016
Q4 2015 -17 -94.9 -122% Oct 1, 2015 Dec 31, 2015
Q3 2015 42.2 +80.7 Jul 1, 2015 Sep 30, 2015
Q2 2015 54.4 +99.4 Apr 1, 2015 Jun 30, 2015
Q1 2015 70.5 +115 Jan 1, 2015 Mar 31, 2015
Q4 2014 77.8 +124 Oct 1, 2014 Dec 31, 2014
Q3 2014 -38.5 +12.9 +25.2% Jul 1, 2014 Sep 30, 2014
Q2 2014 -44.9 +8.62 +16.1% Apr 1, 2014 Jun 30, 2014
Q1 2014 -44.8 +15.5 +25.7% Jan 1, 2014 Mar 31, 2014
Q4 2013 -46.2 +17.3 +27.2% Oct 1, 2013 Dec 31, 2013
Q3 2013 -51.5 +3.53 +6.42% Jul 1, 2013 Sep 30, 2013
Q2 2013 -53.5 +4.28 +7.4% Apr 1, 2013 Jun 30, 2013
Q1 2013 -60.3 Jan 1, 2013 Mar 31, 2013
Q4 2012 -63.5 Oct 1, 2012 Dec 31, 2012
Q3 2012 -55 Jul 1, 2012 Sep 30, 2012
Q2 2012 -57.8 Apr 1, 2012 Jun 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.